Karen M. Olsson
About
Karen M. Olsson is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics.
According to data from OpenAlex, Karen M. Olsson has authored 101 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Pulmonary and Respiratory Medicine, 56 papers in Cardiology and Cardiovascular Medicine and 11 papers in Genetics. Recurrent topics in Karen M. Olsson's work include Pulmonary Hypertension Research and Treatments (83 papers), Cardiovascular Function and Risk Factors (23 papers) and Cardiovascular Issues in Pregnancy (23 papers). Karen M. Olsson is often cited by papers focused on Pulmonary Hypertension Research and Treatments (83 papers), Cardiovascular Function and Risk Factors (23 papers) and Cardiovascular Issues in Pregnancy (23 papers). Karen M. Olsson collaborates with scholars based in Germany, United Kingdom and United States. Karen M. Olsson's co-authors include Marius M. Hoeper, Nils Nickel, Tobias Welte, J. Simon R. Gibbs, Hossein Ardeschir Ghofrani, Heiko Golpon, Ekkehard Grünig, Christian Opitz, Stephan Rosenkranz and Jan Fuge and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.
In The Last Decade
Karen M. Olsson
96 papers receiving 4.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Karen M. Olsson Germany | 34 | 3.9k | 2.7k | 569 | 559 | 299 | 101 | 4.7k | ||
| J. Simon R. Gibbs United Kingdom | 36 | 4.6k 1.2× | 3.4k 1.3× | 652 1.1× | 669 1.2× | 325 1.1× | 78 | 6.0k | ||
| Stephen C. Mathai United States | 43 | 5.9k 1.5× | 3.6k 1.3× | 762 1.3× | 616 1.1× | 329 1.1× | 189 | 7.0k | ||
| Luke Howard United Kingdom | 44 | 4.8k 1.2× | 2.7k 1.0× | 758 1.3× | 680 1.2× | 325 1.1× | 197 | 7.0k | ||
| J. Simon R. Gibbs United Kingdom | 33 | 4.4k 1.1× | 3.2k 1.2× | 464 0.8× | 931 1.7× | 339 1.1× | 78 | 5.8k | ||
| Henning Gall Germany | 30 | 2.7k 0.7× | 2.2k 0.8× | 406 0.7× | 313 0.6× | 177 0.6× | 139 | 3.4k | ||
| Robin Condliffe United Kingdom | 41 | 5.5k 1.4× | 3.5k 1.3× | 565 1.0× | 847 1.5× | 341 1.1× | 161 | 6.6k | ||
| Nick H. Kim United States | 30 | 4.1k 1.1× | 3.1k 1.2× | 401 0.7× | 1.1k 1.9× | 322 1.1× | 108 | 4.7k | ||
| Fumio Sakamaki Japan | 29 | 3.0k 0.8× | 1.9k 0.7× | 466 0.8× | 477 0.9× | 252 0.8× | 87 | 4.1k | ||
| Michael Halank Germany | 33 | 4.3k 1.1× | 3.0k 1.1× | 578 1.0× | 513 0.9× | 540 1.8× | 153 | 5.0k | ||
| E Weitzenblum France | 41 | 7.3k 1.9× | 2.3k 0.9× | 706 1.2× | 643 1.2× | 374 1.3× | 153 | 8.3k |
Countries citing papers authored by Karen M. Olsson
Since
Specialization
Citations
This map shows the geographic impact of Karen M. Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen M. Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen M. Olsson more than expected).
Fields of papers citing papers by Karen M. Olsson
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Karen M. Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen M. Olsson. The network helps show where Karen M. Olsson may publish in the future.
Co-authorship network of co-authors of Karen M. Olsson
This figure shows the co-authorship network connecting the top 25 collaborators of Karen M. Olsson. A scholar is included among the top collaborators of Karen M. Olsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen M. Olsson. Karen M. Olsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Montani, David, Vallerie V. McLaughlin, J. Simon R. Gibbs, et al.. (2025). Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR). American Journal of Respiratory and Critical Care Medicine. 211(6). 1028–1037.
2.
Park, Da‐Hee, Jan Fuge, Jan C. Kamp, et al.. (2024). Reassessing Pulmonary Hypertension Classification: Utilizing Criteria for Heart Failure with Preserved Ejection Fraction Instead of Pulmonary Arterial Wedge Pressure. Journal of Clinical Medicine. 13(24). 7582–7582.
3.
Preston, Ioana R., Luke Howard, David Langleben, et al.. (2024). Management of pulmonary hypertension in special conditions. European Respiratory Journal. 64(4). 2401180–2401180.
4.
Hoeper, Marius M., Hanno Leuchte, Christian Opitz, et al.. (2024). Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study. Circulation. 150(8). 600–610.
5.
Westhoff‐Bleck, Mechthild, Tobias Welte, Da‐Hee Park, et al.. (2024). Doppler‐derived pulmonary pulse transit time measurements in chronic obstructive pulmonary disease: Reproducibility and cardiopulmonary function. Echocardiography. 41(5). e15821–e15821.
6.
Kamp, Jan C., Jan Fuge, Jan Karsten, et al.. (2021). Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension. BMC Pulmonary Medicine. 21(1). 164–164.
7.
Richter, Manuel J., Dominik Berliner, Philipp Douschan, et al.. (2021). Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension. Frontiers in Cardiovascular Medicine. 8. 775039–775039.
8.
Park, Da‐Hee, Jan Fuge, Kai G. Kahl, et al.. (2021). Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension. Frontiers in Psychiatry. 12. 668647–668647.
9.
Czerner, Christoph, Serghei Cebotari, Julius Renne, et al.. (2020). Perioperative CTEPH patient monitoring with 2D phase-contrast MRI reflects clinical, cardiac and pulmonary perfusion changes after pulmonary endarterectomy. PLoS ONE. 15(9). e0238171–e0238171.
10.
Maschke, Sabine, Till F. Kaireit, Serghei Cebotari, et al.. (2018). MRI-derived Regional Biventricular Function in Patients with Chronic Thromboembolic Pulmonary Hypertension Before and After Pulmonary Endarterectomy. Academic Radiology. 25(12). 1540–1547.
11.
Hoeper, Marius M., Christian Apitz, Ekkehard Grünig, et al.. (2018). Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. International Journal of Cardiology. 272. 37–45.
12.
Olsson, Karen M., Christoph B. Wiedenroth, Jan C. Kamp, et al.. (2017). Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience. European Respiratory Journal. 49(6). 1602409–1602409.
13.
Wiedenroth, Christoph B., Karen M. Olsson, Stefan Guth, et al.. (2017). Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease. Pulmonary Circulation. 8(1). 1–6.
14.
Hoeper, Marius M., Katrin Meyer, Jessica Rademacher, et al.. (2016). Diffusion Capacity and Mortality in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction. JACC Heart Failure. 4(6). 441–449.
15.
Olsson, Karen M. & Richard N. Channick. (2016). Pregnancy in pulmonary arterial hypertension. European Respiratory Review. 25(142). 431–437.
16.
Fuehner, Thomas, C. Kuehn, I. Tudorache, et al.. (2012). Extracorporeal Membrane Oxygenation in Awake Patients as Bridge to Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 185(7). 763–768.
17.
Olsson, Karen M., Nils Nickel, Jörn Tongers, & Marius M. Hoeper. (2012). Atrial flutter and fibrillation in patients with pulmonary hypertension. International Journal of Cardiology. 167(5). 2300–2305.
18.
Nickel, Nils, Heiko Golpon, Mark Greer, et al.. (2011). The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. European Respiratory Journal. 39(3). 589–596.
19.
Pape, Lars, et al.. (2009). Prognostic value of computerized quantification of liver fibrosis in children with biliary atresia. Liver Transplantation. 15(8). 876–882.
20.
Nickel, Nils, Tibor Kempf, Jörn Tongers, et al.. (2008). Growth Differentiation Factor-15 in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 178(5). 534–541.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by J. Simon R. Gibbs Breakdown of academic impact, for papers by Stephen C. Mathai Breakdown of academic impact, for papers by Luke Howard Breakdown of academic impact, for papers by J. Simon R. Gibbs Breakdown of academic impact, for papers by Henning Gall Breakdown of academic impact, for papers by Robin Condliffe Breakdown of academic impact, for papers by Nick H. Kim Breakdown of academic impact, for papers by Fumio Sakamaki Breakdown of academic impact, for papers by Michael Halank Breakdown of academic impact, for papers by E Weitzenblum